{"title":"[ILD的诊断]。","authors":"T. Geiser, S. Guler","doi":"10.1024/0040-5930/a000748","DOIUrl":null,"url":null,"abstract":"The diagnosis of ILD is complex and needs a close collaboration between the pulmologist, the radiologist and the pathologist. However, and most importantly, the general practitioner needs to think about the possibility of ILD if a patient presents with increasing shortness of breath, dry cough and bilateral, basal crackles on lung auscultation. Further work-up by the pulmonologist may confirm and classify the ILD by a detailled patient history, lung function tests, CT scans and bronchoscopy, or even surgical lung biospies, if needed. A multidisciplinary discussion (MDD) is becoming the gold standard in diagnosing ILD and deciding about appropriate treatment, in particular regarding the novel antifibrotic therapies for IPF.","PeriodicalId":87030,"journal":{"name":"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale","volume":"6 1","pages":"7-10"},"PeriodicalIF":0.0000,"publicationDate":"2016-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[Diagnosis of ILD].\",\"authors\":\"T. Geiser, S. Guler\",\"doi\":\"10.1024/0040-5930/a000748\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The diagnosis of ILD is complex and needs a close collaboration between the pulmologist, the radiologist and the pathologist. However, and most importantly, the general practitioner needs to think about the possibility of ILD if a patient presents with increasing shortness of breath, dry cough and bilateral, basal crackles on lung auscultation. Further work-up by the pulmonologist may confirm and classify the ILD by a detailled patient history, lung function tests, CT scans and bronchoscopy, or even surgical lung biospies, if needed. A multidisciplinary discussion (MDD) is becoming the gold standard in diagnosing ILD and deciding about appropriate treatment, in particular regarding the novel antifibrotic therapies for IPF.\",\"PeriodicalId\":87030,\"journal\":{\"name\":\"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale\",\"volume\":\"6 1\",\"pages\":\"7-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1024/0040-5930/a000748\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1024/0040-5930/a000748","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The diagnosis of ILD is complex and needs a close collaboration between the pulmologist, the radiologist and the pathologist. However, and most importantly, the general practitioner needs to think about the possibility of ILD if a patient presents with increasing shortness of breath, dry cough and bilateral, basal crackles on lung auscultation. Further work-up by the pulmonologist may confirm and classify the ILD by a detailled patient history, lung function tests, CT scans and bronchoscopy, or even surgical lung biospies, if needed. A multidisciplinary discussion (MDD) is becoming the gold standard in diagnosing ILD and deciding about appropriate treatment, in particular regarding the novel antifibrotic therapies for IPF.